{{short description|Gas used as anesthetic and for pain relief}} {{cs1 config|name-list-style=vanc|display-authors=6}} {{redirect|Gas and air|the 1923 film|Gas and Air (film)}}{{For|details about the substance '''nitrous oxide'''|Nitrous oxide}}{{For|recreational use|Recreational use of nitrous oxide}}{{Infobox drug | drug_name = Nitrous oxide | INN = | class = NMDA receptor antagonist; Dissociative hallucinogen; Analgesic; General anesthetic | ATC_prefix2 = V03 | index_label = Nitrous oxide | index2_label = Oxygen | ATC_suffix2 = AN01 | CAS_number2 = 7782-44-7 | PubChem2 = 977 | DrugBank2 = DB09140 | ChemSpiderID2 = 952 | UNII2 = S88TT14065 | ChEBI2 = 27140 | ChEMBL2 = CHEMBL1234886 | type = combo | IUPAC_name = Nitrous oxide | image = Entonox set.png | alt = | caption = Entonox CD cylinder and giving set <!-- Clinical data -->| pronounce = | tradename = Entonox, Nitronox, others | Drugs.com = | component1 = Nitrous oxide | class1 = Analgesic gas (usually 50%) | component2 = Oxygen | class2 = Medical gas (usually 50%) | MedlinePlus = | pregnancy_AU = <!-- A/B1/B2/B3/C/D/X --> | pregnancy_AU_comment = | pregnancy_US = <!-- A/B/C/D/X/N --> | pregnancy_category = | routes_of_administration = Inhalation | legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> | legal_AU_comment = | legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII --> | legal_DE = <!-- Anlage I, II, III --> | legal_NZ = <!-- Class A, B, C --> | legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM / Class A, B, C --> | legal_US = <!-- OTC/Rx-only/Schedule I, II, III, IV, V --> | legal_UN = <!-- N I, II, III, IV / P I, II, III, IV--> | legal_status = 50/50 mix of nitrous oxide and oxygen: ℞ (prescription only) | bioavailability = | protein_bound = | metabolism = Not metabolized | metabolites = None | onset = 30 seconds<ref name=AnUK2009/> | elimination_half-life = | duration_of_action = 1 minute<ref name=AnUK2009/> | excretion = Exhaled | CAS_number = 10024-97-2 | ATCvet = | ATC_prefix = N01 | ATC_suffix = AX13 | ATC_supplemental = | PubChem = 948 | DrugBank = 06690 | ChemSpiderID = 923 | ChEBI = 17045 | ChEMBL = 1234579 | UNII = K50XQU1029 <!-- Chemical data -->| chemical_formula = N<sub>2</sub>O | N = 2 | O = 1 | molecular_weight = | smiles = [N-]=[N+]=O | StdInChI = 1S/N2O/c1-2-3 | StdInChIKey = GQPLMRYTRLFLPF-UHFFFAOYSA-N }}

'''Nitrous oxide,''' as medical gas supply, is an inhaled gas used as pain medication, and is typically administered with 50% oxygen mix. It is often used together with other medications for anesthesia.<ref name="WHO2008" /> Common uses include during childbirth, following trauma, and as part of end-of-life care.<ref name="WHO2008" /> Onset of effect is typically within half a minute, and the effect lasts for about a minute.<ref name="AnUK2009">{{cite web|title=Anaesthesia UK: Entonox|url=http://www.frca.co.uk/article.aspx?articleid=100364|website=www.frca.co.uk|access-date=15 December 2016|date=26 January 2009|url-status=live|archive-url=https://web.archive.org/web/20071031101605/http://www.frca.co.uk/article.aspx?articleid=100364|archive-date=31 October 2007}}</ref>

Nitrous oxide was discovered between 1772 and 1793 and used for anesthesia in 1844.<ref name=My2007>{{cite book| vauthors = Myers RL |title=100 Most Important Chemical Compounds, The: A Reference Guide: A Reference Guide|date=2007|publisher=ABC-CLIO|isbn=978-0-313-08057-9|page=198|url=https://books.google.com/books?id=nKtzCgAAQBAJ&pg=PA198|language=en|url-status=live|archive-url=https://web.archive.org/web/20161220133035/https://books.google.ca/books?id=nKtzCgAAQBAJ&pg=PA198|archive-date=2016-12-20}}</ref> It is on the World Health Organization's List of Essential Medicines.<ref name="WHO22nd">{{cite book | title = World Health Organization model list of essential medicines: 22nd list (2021) | year = 2021 | hdl = 10665/345533 | publisher = World Health Organization | location = Geneva | id = WHO/MHP/HPS/EML/2021.02 | hdl-access=free }}</ref> It often comes as a 50/50 mixture with oxygen.<ref name=AnUK2009/> Devices with a demand valve are available for self-administration.<ref name=BNF69>{{cite book|title=British national formulary: BNF 69|date=2015|publisher=British Medical Association|isbn=978-0-85711-156-2|page=878|edition=69}}</ref> The setup and maintenance is relatively inexpensive for developing countries.<ref>{{cite book| vauthors = Gregory GA, Andropoulos DB |title=Gregory's Pediatric Anesthesia, With Wiley Desktop Edition|date=2012|publisher=John Wiley & Sons|isbn=978-1-4443-3346-6|page=1148|url=https://books.google.com/books?id=Y43oypp8QHkC&pg=PA1148|language=en|url-status=live|archive-url=https://web.archive.org/web/20161220132746/https://books.google.ca/books?id=Y43oypp8QHkC&pg=PA1148|archive-date=2016-12-20}}</ref><ref>{{cite book |title=WHO model prescribing information: drugs used in anaesthesia |date=1989 |publisher=World Health Organization |hdl=10665/41014 |hdl-access=free |isbn=92-4-140101-X }}</ref>

There are few side effects, other than vomiting, with short-term use.<ref name=AnUK2009/><ref name=WHO2008/> With long-term use anemia or numbness may occur.<ref name=WHO2008/> It should always be given with at least 21% oxygen.<ref name=WHO2008/> It is not recommended in people with a bowel obstruction or pneumothorax.<ref name=WHO2008>{{cite book | title = WHO Model Formulary 2008 | year = 2009 | isbn = 978-92-4-154765-9 | veditors = Stuart MC, Kouimtzi M, Hill SR | hdl = 10665/44053 | publisher = World Health Organization | hdl-access=free | page=20 }}</ref> Use in the early part of pregnancy is not recommended.<ref name=AnUK2009/> It is possible to continue breastfeeding following use.<ref>{{cite web|title=Nitrous Oxide use while Breastfeeding |url=https://www.drugs.com/breastfeeding/nitrous-oxide.html|website=Drugs.com |access-date=15 December 2016|url-status=live|archive-url=https://web.archive.org/web/20161221011018/https://www.drugs.com/breastfeeding/nitrous-oxide.html|archive-date=21 December 2016}}</ref>

==History== thumb|Administration of nitrous oxide, 1870<ref>{{cite web | vauthors = Thomas FR |title=Manual of the discovery, manufacture, and administration of nitrous oxide, or laughing gas in its relations to dental or minor surgical operations, and particularly for the painless extraction of teeth |url=https://archive.org/details/manualofdiscover1870thom |publisher=Philadelphia : S.S. White |access-date=17 December 2018 |date=1870}}</ref> Pure N<sub>2</sub>O was first used as a medical analgesic in December 1844, when Horace Wells made the first 12–15 dental operations with the gas in Hartford.<ref name="Discovery of Wells">{{cite journal | vauthors = Erving HW | title = The Discoverer of Anæsthesia: Dr. Horace Wells of Hartford | journal = The Yale Journal of Biology and Medicine | volume = 5 | issue = 5 | pages = 421–430 | date = May 1933 | pmid = 21433572 | pmc = 2606479 | url = http://ukpmc.ac.uk/picrender.cgi?artid=1703729&blobtype=pdf | archive-url = https://archive.today/20121223094038/http://ukpmc.ac.uk/picrender.cgi?artid=1703729&blobtype=pdf | archive-date = 2012-12-23 }}</ref><ref name=boc>{{cite web|publisher=BOC Gases|title=History of Entonox|url=http://www.entonox.co.uk/en/discover_enotonox/story_and_heritage/index.shtml|archive-url=https://web.archive.org/web/20090705234343/http://www.entonox.co.uk/en/discover_enotonox/story_and_heritage/index.shtml|archive-date=2009-07-05|access-date=2009-04-11}}</ref>

Its debut as a generally accepted method, however, came in 1863, when Gardner Quincy Colton introduced it more broadly at all the Colton Dental Association clinics, that he founded in New Haven and New York City.<ref name="Drug discovery">{{cite book|url=https://books.google.com/books?id=mYQxRY9umjcC | vauthors = Sneader W |title=Drug Discovery –A History | chapter = Part 1: Legacy of the past, chapter 8: systematic medicine | pages = 74–87 |year=2005 |access-date=21 April 2010 |publisher=John Wiley and Sons |isbn=978-0-471-89980-8}}</ref>

The first devices used in dentistry to administer the gas consisted of a simple breathing bag made of rubber cloth.<ref name="use in dentistry">{{cite journal| vauthors = Miller AH |title=Technical Development of Gas Anesthesia |journal=Anesthesiology |volume=2 |issue=4 |pages=398–409 |year=1941 |doi=10.1097/00000542-194107000-00004|s2cid=71117361 |doi-access=free }}</ref>

Breathing the pure gas often caused hypoxia (oxygen insufficiency) and sometimes death by asphyxiation. Eventually practitioners became aware of the need to provide at least 21% oxygen content in the gas (the same percentage as in air).<ref name=boc/> In 1911, the anaesthetist Arthur Ernest Guedel first described the use of self-administration of a nitrous oxide and oxygen mix. It was not until 1961 that the first paper was published by Michael Tunstall and others, describing the administration of a pre-mixed 50:50 nitrous oxide and oxygen mix, which led to the commercialisation of the product.<ref name=boc/>

In 1970, Peter Baskett recognised that pre-mixed nitrous oxide and oxygen mix could have an important part to play in the provision of pre-hospital pain relief management, provided by ambulance personnel. Baskett contacted the Chief Ambulance Officer for the Gloucestershire Ambulance Brigade, Alan Withnell, to suggest this idea. This gained traction when Baskett negotiated with the British Oxygen Company, the availability of pre-mixed nitrous oxide and oxygen mix apparatus for training. Regular training sessions began at Frenchay Hospital (Bristol) and a pilot study was run in Gloucestershire (in which ambulances were crewed by a driver and one of the new highly trained ambulance men), the results of this trial were published in 1970.<ref>{{cite journal | vauthors = Baskett PJ | title = Use of Entonox in the ambulance service | journal = British Medical Journal | volume = 2 | issue = 5700 | pages = 41–43 | date = April 1970 | pmid = 5440577 | pmc = 1699783 | doi = 10.1136/bmj.2.5700.41 }}</ref>

Today the nitrous oxide is administered in hospitals by a relative analgesia machine, which includes several improvements such as flowmeters and constant-flow regulators, an anaesthetic vaporiser, a medical ventilator, and a scavenger system, and delivers a precisely dosed and breath-actuated flow of nitrous oxide mixed with oxygen.{{cn|date=March 2022}}

The machine used in dentistry is much simpler, and is meant to be used by the patient in a fully conscious state. The gas is delivered through a demand-valve inhaler over the nose, which will only release gas when the patient inhales through it.{{cn|date=March 2022}}

==Medical uses== Nitrous oxide (N<sub>2</sub>O) is itself active (does not require any changes in the body to become active), and so has an onset in roughly the lungbrain circulation time with peak action 30 seconds after the start of administration.<ref name=AnUK2009/> It is removed from the body unchanged via the lungs, and does not accumulate under normal conditions, explaining the rapid offset of around 60 seconds.<ref name=AnUK2009/> It is effective in managing pain during labor and delivery.<ref name=Coch2012>{{cite journal | vauthors = Jones L, Othman M, Dowswell T, Alfirevic Z, Gates S, Newburn M, Jordan S, Lavender T, Neilson JP | title = Pain management for women in labour: an overview of systematic reviews | journal = The Cochrane Database of Systematic Reviews | volume = 2012 | issue = 3 | article-number = CD009234 | date = March 2012 | pmid = 22419342 | pmc = 7132546 | doi = 10.1002/14651858.CD009234.pub2 }}</ref>

Nitrous oxide has been shown to be an effective and safe treatment for alcohol withdrawal.<ref>Gillman M.A, Lichtigfeld, F.J. 2004 Enlarged double-blind randomised trial of benzodiazepines against psychotropic analgesic nitrous oxide for alcohol withdrawal, ''Addictive Behaviors'', Volume 29, Issue 6, Pages 1183–1187</ref>

Nitrous oxide is more soluble than oxygen and nitrogen, so will tend to diffuse into any air spaces within the body. This makes it dangerous to use in patients with pneumothorax or those who have recently been scuba diving, and there are cautions over its use with any bowel obstruction.

Its analgesic effect is strong (equivalent to 15&nbsp;mg of subcutaneous route morphine<ref name=AnUK2009/>)<ref>{{cite journal | vauthors = Gao HX, Zhang JJ, Liu N, Wang Y, Ma CX, Gao LL, Liu Q, Zhang TT, Wang YL, Bao WQ, Li YX | title = A fixed nitrous oxide/oxygen mixture as an analgesic for patients with postherpetic neuralgia: study protocol for a randomized controlled trial | journal = Trials | volume = 22 | issue = 1 | article-number = 29 | date = January 2021 | pmid = 33407845 | pmc = 7787626 | doi = 10.1186/s13063-020-04960-5 | doi-access = free }}</ref><ref>{{cite journal | vauthors = Parbrook GD | title = The levels of nitrous oxide analgesia | journal = British Journal of Anaesthesia | volume = 39 | issue = 12 | pages = 974–982 | date = December 1967 | pmid = 4865545 | doi = 10.1093/bja/39.12.974 | doi-access = free }}</ref> and characterised by rapid onset and offset, i.e. it is very fast-acting and wears off very quickly.{{cn|date=December 2022}}

When used in combination with other anesthetics gases, nitrous oxide causes a dose dependent increased respiratory rate and decreased tidal volumes, the net effect is a lower minute ventilation. Like volatile anesthetics, it increases cerebral blood flow and intracranial pressure. However, contrary to volatile anesthetics, it leads to an increase in cerebral metabolic rate of oxygen.<ref>{{cite book | vauthors = Clar DT, Patel S, Richards JR |chapter=Anesthetic Gases |title=StatPearls |date=2022 |id={{NCBIBook2|NBK537013}} |pmid=30725698 }}</ref><ref>{{cite book | vauthors = Knuf K, Maani CV |chapter=Nitrous Oxide |title=StatPearls |date=2022 |id={{NCBIBook2|NBK532922}} |pmid=30422517 }}</ref>

==Contraindications== N<sub>2</sub>O should not be used in patients with bowel obstruction, pneumothorax, or middle ear or sinus disease,<ref name=AnUK2009/> or who have had a recent intraocular injection of gas<ref>{{Cite web |title=Entonox: The essential guide |url=https://www.boconline.co.uk/wcsstore/UK_BOC_Industrial_Ntl_Store/pdf/downloads/Entonox-essential-guide.pdf |access-date=2023-12-24 |website=BOC online}}</ref> and should also not be used on any patient who has been scuba diving within the preceding 24 hours<ref name=SPUMS1998>{{cite journal | vauthors = Komesaroff D |title=Oxygen administration in diving accidents |journal=South Pacific Underwater Medicine Society Journal |year=1998 |volume=28 |issue=3 Supplement }}</ref> or in violently disturbed psychiatric patients.<ref name=jrcalc>{{cite book|publisher=Joint Royal Colleges Ambulance Liaison Committee|title=UK Ambulance Service Clinical Practice Guidelines|year=2006|url=http://www2.warwick.ac.uk/fac/med/research/hsri/emergencycare/prehospitalcare/jrcalcstakeholderwebsite/guidelines/clinical_guidelines_2006.pdf | vauthors = Fisher J, Brown S, Cooke M |isbn=978-1-84690-060-0|url-status=live|archive-url=https://web.archive.org/web/20110605073519/http://www2.warwick.ac.uk/fac/med/research/hsri/emergencycare/prehospitalcare/jrcalcstakeholderwebsite/guidelines/clinical_guidelines_2006.pdf|archive-date=2011-06-05}}</ref> There are also clinical cautions in place for the first two trimesters of pregnancy and in patients with decreased levels of consciousness.<ref name=AnUK2009/>

==Composition==

The gas is a mixture of half nitrous oxide (N<sub>2</sub>O) and half oxygen (O<sub>2</sub>).<ref name=AnUK2009/><ref name=jrcalc/> The ability to combine N<sub>2</sub>O and oxygen at high pressure while remaining in the gaseous form is caused by the Poynting effect (after John Henry Poynting, an English physicist).<ref name=AnUK2009/> The Poynting effect involves the dissolution of gaseous O<sub>2</sub> when bubbled through liquid N<sub>2</sub>O, with vaporisation of the liquid to form a gaseous O<sub>2</sub>/N<sub>2</sub>O mixture.<ref name=AnUK2009/>

Since the two substances are homogeneously mixed gases, the cylinder delivers a consistent 50/50 mixture all the way down to empty, even if the cylinder adiabatically cools somewhat from the discharge.<ref name=Litwin2010/>

Some N<sub>2</sub>O may condense into a liquid if the cylinder is cooled to low temperatures (−7&nbsp;°C or below), which can be dangerous if unaddressed.<ref name=Litwin2010>{{cite journal|doi=10.1186/1471-2253-10-19|doi-access=free |title=The effects of temperature on nitrous oxide and oxygen mixture homogeneity and stability |date=2010 |journal=BMC Anesthesiology |volume=10 |article-number=19 |pmid=20950473 |pmc=2967548 | vauthors = Litwin PD }}</ref> This occurs most easily with partially used / lower pressure cylinders. Even after warming the contents back into a gaseous state, they may remain nonhomogenous for days. Thus it is typically instructed to warm cylinders in a horizontal orientation (to maximize heat transfer) for a 48 hour period, then rehomogenize the gas by inverting the cylinder three times.<ref name=Litwin2010/>

<gallery> File:Entonox Shoulder.png|Distinct blue and white cap of an Entonox cylinder File:Entonox schrader valve.png|Typical Schrader valve attachment, making the gas usable only with demand based giving sets </gallery>

==Administration== [[File:An Operation at the Military Hospital, Endell Street - Dr L Garrett, Dr Flora Murray, Dr W Buckley Art.IWMART4084.jpg|thumb|Surgeons at Endell Street Military Hospital operating on an anaesthetised soldier during World War&nbsp;I. In the foreground, the anaesthetist is holding a mask in front of the patient's face.]] The gas is self-administered through a demand valve, using a mouthpiece, bite block or face mask.<ref name=jrcalc/> Self-administration of Entonox is safe because if enough is inhaled to start to induce anaesthesia, the patient becomes unable to hold the valve, and so will drop it and soon exhale the residual gas. This means that unlike other anaesthetic gases, it does not require the presence of an anaesthetist for administration. The 50% oxygen in Entonox ensures the person will have sufficient oxygen in their alveoli and conducting airways for a short period of apnea to be safe.{{cn|date=March 2022}}

== Mechanism of action == {{Main|Nitrous oxide#Mechanism of action}} The pharmacological mechanism of action of {{chem|N|2|O}} in medicine is not fully known. However, it has been shown to directly modulate a broad range of ligand-gated ion channels, and this likely plays a major role in many of its effects. It moderately blocks NMDAR and β{{sub|2}}-subunit-containing nACh channels, weakly inhibits AMPA, kainate, GABA{{sub|C}} and 5-HT{{sub|3}} receptors, and slightly potentiates GABA{{sub|A}} and glycine receptors.<ref name="pmid11020766">{{cite journal | vauthors = Yamakura T, Harris RA | title = Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol | journal = Anesthesiology | volume = 93 | issue = 4 | pages = 1095–1101 | date = October 2000 | pmid = 11020766 | doi = 10.1097/00000542-200010000-00034 | s2cid = 4684919 | doi-access = free }}</ref><ref name="pmid9822732">{{cite journal | vauthors = Mennerick S, Jevtovic-Todorovic V, Todorovic SM, Shen W, Olney JW, Zorumski CF | title = Effect of nitrous oxide on excitatory and inhibitory synaptic transmission in hippocampal cultures | journal = The Journal of Neuroscience | volume = 18 | issue = 23 | pages = 9716–9726 | date = December 1998 | pmid = 9822732 | pmc = 6793274 | doi = 10.1523/JNEUROSCI.18-23-09716.1998 }}</ref> It also has been shown to activate two-pore-domain {{chem|K|+}} channels.<ref name="pmid14742687">{{cite journal | vauthors = Gruss M, Bushell TJ, Bright DP, Lieb WR, Mathie A, Franks NP | title = Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane | journal = Molecular Pharmacology | volume = 65 | issue = 2 | pages = 443–452 | date = February 2004 | pmid = 14742687 | doi = 10.1124/mol.65.2.443 | s2cid = 7762447 }}</ref> While {{chem|N|2|O}} affects quite a few ion channels, its anesthetic, hallucinogenic and euphoriant effects are likely caused predominantly, or fully, via inhibition of NMDA receptor-mediated currents.<ref name="pmid11020766" /><ref name="pmid17352529">{{cite journal | vauthors = Emmanouil DE, Quock RM | title = Advances in understanding the actions of nitrous oxide | journal = Anesthesia Progress | volume = 54 | issue = 1 | pages = 9–18 | year = 2007 | pmid = 17352529 | pmc = 1821130 | doi = 10.2344/0003-3006(2007)54[9:AIUTAO]2.0.CO;2 }}</ref> In addition to its effects on ion channels, {{chem|N|2|O}} may act to imitate nitric oxide (NO) in the central nervous system, and this may be related to its analgesic and anxiolytic properties.<ref name="pmid17352529" /> Nitrous oxide is 30 to 40 times more soluble than nitrogen{{citation needed|date=November 2025}}.

==Society and culture== Nitronox was a registered trademark of the BOC Group between 1966 and 1999,<ref>{{cite web|url=http://www.trademarkia.com/nitronox-73134512.html|publisher=trademarkia|title=NITRONOX Trademark Information|access-date=2017-07-11|url-status=live|archive-url=https://web.archive.org/web/20170910183026/http://www.trademarkia.com/nitronox-73134512.html|archive-date=2017-09-10}}</ref> and was reregistered by Hs Tm Inc since 2005{{cn|date=October 2022}} It is also colloquially known as "gas and air" in the United Kingdom.<ref>{{cite web|publisher=Baby Centre|title=Entonox (gas and air)|url=http://www.babycentre.co.uk/pregnancy/labourandbirth/painrelief/entonox/|url-status=live|archive-url=https://web.archive.org/web/20061111122706/http://www.babycentre.co.uk/pregnancy/labourandbirth/painrelief/entonox/|archive-date=2006-11-11}}</ref>

==Research== Investigational trials show potential for antidepressant applications of N<sub>2</sub>O, especially for treatment-resistant forms of depression, and it is rapid-acting.<ref>{{cite journal | vauthors = Nagele P, Duma A, Kopec M, Gebara MA, Parsoei A, Walker M, Janski A, Panagopoulos VN, Cristancho P, Miller JP, Zorumski CF, Conway CR | title = Nitrous Oxide for Treatment-Resistant Major Depression: A Proof-of-Concept Trial | journal = Biological Psychiatry | volume = 78 | issue = 1 | pages = 10–18 | date = July 2015 | pmid = 25577164 | doi = 10.1016/j.biopsych.2014.11.016 | doi-access = free }}</ref><ref>{{cite journal | vauthors = Newport DJ, Carpenter LL, McDonald WM, Potash JB, Tohen M, Nemeroff CB | title = Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression | journal = The American Journal of Psychiatry | volume = 172 | issue = 10 | pages = 950–966 | date = October 2015 | pmid = 26423481 | doi = 10.1176/appi.ajp.2015.15040465 | doi-access = free }}</ref><ref name="Nagele_2021">{{cite journal | vauthors = Nagele P, Palanca BJ, Gott B, Brown F, Barnes L, Nguyen T, Xiong W, Salloum NC, Espejo GD, Lessov-Schlaggar CN, Jain N, Cheng WW, Komen H, Yee B, Bolzenius JD, Janski A, Gibbons R, Zorumski CF, Conway CR | title = A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression | journal = Science Translational Medicine | volume = 13 | issue = 597 | article-number = eabe1376 | date = June 2021 | pmid = 34108247 | doi = 10.1126/scitranslmed.abe1376 | s2cid = 235381316 }}</ref><ref>{{Cite web| vauthors = Mozes A |date=2021-06-10|title='Laughing Gas' May Help Tough-to-Treat Depression|url=https://www.webmd.com/depression/news/20210610/laughing-gas-may-help-tough-to-treat-depression|access-date=2021-06-15|website=WebMD|language=en}}</ref><ref>{{cite journal | vauthors = de Leon VC, Kumar A, Nagele P, Palanca BJ, Gott B, Janski A, Zorumski CF, Conway CR | title = Nitrous Oxide Reduced Suicidal Ideation in Treatment-Resistant Major Depression in Exploratory Analysis | language = English | journal = The Journal of Clinical Psychiatry | volume = 84 | issue = 5 | page = 48436 | date = August 2023 | pmid = 37585253 | doi = 10.4088/JCP.22br14725 | pmc = 11097146 }}</ref> In a phase 2 clinical trial, a treatment with 25% nitrous oxide had comparable efficacy to 50% nitrous oxide but was associated with significantly fewer adverse effects.<ref name="Nagele_2021" />

== References == {{Reflist}}

== Further reading == {{refbegin}} * {{cite book| vauthors = Clark MS, Brunick A |title=Handbook of Nitrous Oxide and Oxygen Sedation|date=2014|publisher=Elsevier Health Sciences|isbn=978-0-323-10130-1|url=https://books.google.com/books?id=RHDkAwAAQBAJ&pg=PP253|language=en}} {{refend}}

== External links == * {{cite web | url = http://www.babycentre.co.uk/pregnancy/labourandbirth/painrelief/entonox/ | work = BabyCentre | title = Entonox | archive-url = https://web.archive.org/web/20061111122706/http://www.babycentre.co.uk/pregnancy/labourandbirth/painrelief/entonox/ | archive-date = 2006-11-11 }} * {{cite web | vauthors = Hilton A | url = http://www.suslik.org/FirstAid/Kit/entonox.html | title = Entonox | work = www.suslik.org | archive-url = https://web.archive.org/web/20040827111940/http://www.suslik.org/FirstAid/Kit/entonox.html | archive-date = 2004-08-27 }}

{{portal bar|Medicine}} {{Alcohol and health}}

{{DEFAULTSORT:Nitrous Oxide And Oxygen}} Category:Breathing gases Category:Emergency medical equipment Category:First aid Category:General anesthetics Category:Oxygen Category:Pain management Category:World Health Organization essential medicines Category:Wikipedia medicine articles ready to translate